Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The role of B cell immunity in VCA graft rejection and acceptance.

Kaufman CL, Cascalho M, Ozyurekoglu T, Jones CM, Ramirez A, Roberts T, Tien HY, Moreno R, Galvis E, Tsai TM, Palazzo M, Farner S, Platt JL.

Hum Immunol. 2019 Jun;80(6):385-392. doi: 10.1016/j.humimm.2019.03.002. Epub 2019 Mar 2. Review.

PMID:
30836129
2.

Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.

Kueckelhaus M, Fischer S, Seyda M, Bueno EM, Aycart MA, Alhefzi M, ElKhal A, Pomahac B, Tullius SG.

Transpl Int. 2016 Jun;29(6):655-62. doi: 10.1111/tri.12652. Epub 2015 Sep 14. Review.

3.

Monitoring and long-term outcomes in vascularized composite allotransplantation.

Kaufman CL, Ouseph R, Marvin MR, Manon-Matos Y, Blair B, Kutz JE.

Curr Opin Organ Transplant. 2013 Dec;18(6):652-8. doi: 10.1097/MOT.0000000000000025. Review.

PMID:
24220047
4.

Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.

Wang HD, Fidder SAJ, Miller DT, Furtmüller GJ, Ahmadi AR, Nägele F, Lopez J, Quan A, Budihardjo J, Lough DM, Akpinarli B, Etra JW, Vasilic D, Raimondi G, Lee WPA, Montgomery RA, Sun Z, Brandacher G.

Transplantation. 2018 Apr;102(4):593-600. doi: 10.1097/TP.0000000000002070.

PMID:
29298238
5.

Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.

Kanitakis J, Petruzzo P, Badet L, Gazarian A, Thaunat O, Testelin S, Devauchelle B, Dubernard JM, Morelon E.

Transplantation. 2016 Oct;100(10):2053-61. doi: 10.1097/TP.0000000000001248. Review.

PMID:
27163543
6.

Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.

Jindal R, Unadkat J, Zhang W, Zhang D, Ng TW, Wang Y, Jiang J, Lakkis F, Rubin P, Lee WP, Gorantla VS, Zheng XX.

Am J Transplant. 2015 May;15(5):1231-40. doi: 10.1111/ajt.13118. Epub 2015 Feb 12.

7.

Chronic rejection in vascularized composite allografts.

Mundinger GS, Drachenberg CB.

Curr Opin Organ Transplant. 2014 Jun;19(3):309-14. doi: 10.1097/MOT.0000000000000073. Review.

PMID:
24811439
8.

Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?

Thaunat O, Badet L, Dubois V, Kanitakis J, Petruzzo P, Morelon E.

Curr Opin Organ Transplant. 2015 Dec;20(6):596-601. doi: 10.1097/MOT.0000000000000242. Review.

PMID:
26536419
9.

Mechanisms of rejection in vascular composite allotransplantation.

Etra JW, Raimondi G, Brandacher G.

Curr Opin Organ Transplant. 2018 Feb;23(1):28-33. doi: 10.1097/MOT.0000000000000490. Review.

PMID:
29189293
10.

De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation - a retrospective study.

Weissenbacher A, Vrakas G, Chen M, Reddy S, Allan P, Giele H, Barnardo MCNM, Vaidya A, Friend PJ, Fuggle SV.

Transpl Int. 2018 Apr;31(4):398-407. doi: 10.1111/tri.13096. Epub 2017 Dec 14.

11.

Vascularized composite allografts and solid organ transplants: similarities and differences.

Weissenbacher A, Hautz T, Pratschke J, Schneeberger S.

Curr Opin Organ Transplant. 2013 Dec;18(6):640-4. doi: 10.1097/MOT.0000000000000019. Review.

PMID:
24126807
12.

Novel immunological and clinical insights in vascularized composite allotransplantation.

Kollar B, Pomahac B, Riella LV.

Curr Opin Organ Transplant. 2019 Feb;24(1):42-48. doi: 10.1097/MOT.0000000000000592.

PMID:
30531538
13.

Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.

Olariu R, Denoyelle J, Leclère FM, Dzhonova DV, Gajanayake T, Banz Y, Hayoz M, Constantinescu M, Rieben R, Vögelin E, Taddeo A.

J Surg Res. 2017 Oct;218:49-57. doi: 10.1016/j.jss.2017.05.046. Epub 2017 Jun 10.

PMID:
28985877
14.

Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology.

Leonard DA, Kurtz JM, Cetrulo CL Jr.

Curr Opin Organ Transplant. 2013 Dec;18(6):645-51. doi: 10.1097/MOT.0000000000000022. Review.

PMID:
24126805
15.

De novo belatacept in clinical vascularized composite allotransplantation.

Cendales LC, Ruch DS, Cardones AR, Potter G, Dooley J, Dore D, Orr J, Ruskin G, Song M, Chen DF, Selim MA, Kirk AD.

Am J Transplant. 2018 Jul;18(7):1804-1809. doi: 10.1111/ajt.14910. Epub 2018 Jun 9.

16.

Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research.

Fleissig Y, Reed RM, Beare JE, LeBlanc AJ, Williams SK, Kaufman CL, Hoying JB.

J Vis Exp. 2019 Apr 26;(146). doi: 10.3791/59458.

PMID:
31081823
17.

The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.

Shanmugarajah K, Powell H, Leonard DA, Mallard C, Albritton A, Harrington E, Randolph MA, Farkash E, Sachs DH, Kurtz JM, Cetrulo CL Jr.

Am J Transplant. 2017 Jul;17(7):1729-1741. doi: 10.1111/ajt.14189. Epub 2017 Feb 8.

18.

A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.

Chen B, Xu H, Corbin DR, Ildstad ST.

Transplantation. 2012 Oct 15;94(7):671-8. doi: 10.1097/TP.0b013e318264fbc1.

PMID:
22948444
19.

Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.

Mathes DW, Chang J, Hwang B, Graves SS, Storer BE, Butts-Miwongtum T, Sale GE, Storb R.

Transplantation. 2014 Jul 27;98(2):131-8. doi: 10.1097/TP.0000000000000204.

20.

Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.

Weissenbacher A, Loupy A, Chandraker A, Schneeberger S.

Curr Opin Organ Transplant. 2016 Oct;21(5):510-5. doi: 10.1097/MOT.0000000000000349. Review.

PMID:
27517505

Supplemental Content

Support Center